Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Strathdee

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Cancer Research|October 6, 2005
CpG island methylation of DNA damage response genes in advanced ovarian cancerJens M Teodoridis, Jacqueline Hall, Sharon Marsh, et al.
Biogerontology|April 29, 2014
Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+ StudyJoanna Collerton, Hannah E Gautrey, Sanne D van Otterdijk, et al.
British Journal of Cancer|October 21, 2020
Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemiaTimothy M Barrow, Sirintra Nakjang, Fadhel Lafta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosisGordon Strathdee, Tessa L Holyoake, Alyson Sim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markersSusan H Wei, Chuan-Mu Chen, Gordon Strathdee, et al.
Molecular Cancer|April 10, 2026
Author's Response to the Commentary by Raitoharju E et al. on "Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth"Farah J Nassar, Vincent Cahais, Jill A McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumorsKim Appleton, Helen J Mackay, Ian Judson, et al.
Familial Cancer|July 26, 2012
Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminomaStephanie Smetsers, Joanne Muter, Claire Bristow, et al.
Epigenetics|August 4, 2015
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemiaAlem S Gabriel, Fadhel M Lafta, Edward C Schwalbe, et al.
British Journal of Cancer|March 31, 2022
Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivorsNatassia Robinson, John Casement, Marc J Gunter, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cancer Research|October 6, 2005
CpG island methylation of DNA damage response genes in advanced ovarian cancerJens M Teodoridis, Jacqueline Hall, Sharon Marsh, et al.
Biogerontology|April 29, 2014
Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+ StudyJoanna Collerton, Hannah E Gautrey, Sanne D van Otterdijk, et al.
British Journal of Cancer|October 21, 2020
Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemiaTimothy M Barrow, Sirintra Nakjang, Fadhel Lafta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosisGordon Strathdee, Tessa L Holyoake, Alyson Sim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markersSusan H Wei, Chuan-Mu Chen, Gordon Strathdee, et al.
Molecular Cancer|April 10, 2026
Author's Response to the Commentary by Raitoharju E et al. on "Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth"Farah J Nassar, Vincent Cahais, Jill A McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumorsKim Appleton, Helen J Mackay, Ian Judson, et al.
Familial Cancer|July 26, 2012
Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminomaStephanie Smetsers, Joanne Muter, Claire Bristow, et al.
Epigenetics|August 4, 2015
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemiaAlem S Gabriel, Fadhel M Lafta, Edward C Schwalbe, et al.
British Journal of Cancer|March 31, 2022
Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivorsNatassia Robinson, John Casement, Marc J Gunter, et al.
Pageof 5